Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Keywords: 1-integrin; 13-hydroxyoctadecadienoic acid; E-cadherin; Melatonin; Neuroendocrin; anastroxole; angiogenesis; antiaromatases; antioxidant; aortic smooth muscle; apoptotic induced factor; calmodulin (CaM); cancer; carbonic anhydrase IX; cervical cancer; colorectal cancer; cytodifferentiating effects; cytosolic proteases; epidermal growth factor receptor (EGFR); epigenetic effects; estrogen signalling pathway; estrogen sulfotransferases; estrogenic receptor; exemestrane; hepatocarcinomas; ifosfamide; immunoenhancing; indoleamine; larynx carcinomas; letrozole; lymphocytes; lymphoid organs; malignant neoplasias; malignant tumors; melanoma; melatonin; mesenchymal stem cells; metastasis; mitogenactivated protein kinase (MAPK); mitogenic proteins; neoplasias; neoplastic diseases; neural tumors; neuroendocrine-reproductive; osteoblasts; pinealectomy; reactive oxygen species; sarcomas; suprachiasmatic nuclei; telomerase; telomerase activity; vincristine; xenoestrogens
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.